Dr. Safai Haeri's primary research focus includes prevention and treatment of osteoporosis. He has special interest in the impact of osteoporosis pharmacotherapies on muscle health.
Dr. Safai Haeri is dually trained in Endocrinology and Geriatric Medicine. His clinical interests include metabolic bone disorders, osteoporosis, parathyroid and calcium disorders.
- MD, IUMS School of Medicine, 2009
- Certificate in Clinical Research, University of Pittsburgh
- Residency and Chief Residency, Internal Medicine, The Brooklyn Hospital Center, 2017
- Fellowship, Geriatric Medicine, Icahn School of Medicine at Mount Sinai, 2019
- Fellowship, Endocrinology, University of Pittsburgh Medical Center, 2021
- NIH T32 Fellowship, Endocrinology and Geriatric Medicine, University of Pittsburgh, 2022
Education & Training
Safai Haeri N, Perera S, Greenspan SL. Does Zoledronic Acid Improve Appendicular Lean Mass in Older Women with Osteoporosis? A Sub-Analysis of a Randomized Clinical Trial. The Journal of Frailty & Aging. 2022; 11(4)
Safai Haeri N, Kotlarczyk MP, Perera S, Greenspan SL. Diabetes Mellitus is Associated with Poor Bone Microarchitecture in Older Adults Residing in Long-Term Care Facilities. Journal of Osteoporosis. 2022
Safai Haeri N, Perera S, Greenspan SL. The Association of Bone Turnover Markers with Muscle Function, Falls, and Frailty in Older Women in Long-Term Care. The Journal of Frailty & Aging. 2023; 12(4)
Safai Haeri N, Perera S, Ferreiro I, Hans D, Greenspan SL. Trabecular bone score in the hip: a new method to examine hip bone microarchitecture-a feasibility study. Archives of Osteoporosis. 2022; 17(1)
Safai Haeri N, Perera S, Greenspan SL. The association of vitamin D with bone microarchitecture, muscle strength, and mobility performance in older women in long-term care. Bone. 2023
Safai Haeri N, Perera S, Nadkarni NK, Greenspan SL. Association of inflammatory markers with muscle and cognitive function in early and late-aging older adults. The Journal of Nutrition, Health and Aging. 2024; 28(5)
Safai Haeri N, Perera S, Greenspan SL. Impact of denosumab on muscle health in older adults in long-term care. Bone. 2025
Safai Haeri N, Perera S, Greenspan SL. Impact of Zoledronic Acid on Bone Mineral Density and Trabecular Score Following Denosumab Discontinuation in Older Adults in Long-Term Care. Calcifed Tissue International. 2025; 116(1)
- Chief Fellow Recognition Award, 2019
- Endocrine Society Helmsley Charitable Trust Award, 2021
- Claude D. Pepper Scholar, 2022
- National Institutes of Health (NIH/NIA) K23 Award, 2025
Title: Impact of Different Classes of Osteoporosis Medications on Muscle Health in Older Adults
Role: Principal Investigator
Funding Agency: National Institute of Health
Grant Number: K23 AG088498
Start Year: 2025
End Year: 2030
